Arvida Group Past Earnings Performance
Past criteria checks 1/6
Arvida Group has been growing earnings at an average annual rate of 19.1%, while the Healthcare industry saw earnings growing at 13.7% annually. Revenues have been growing at an average rate of 10.1% per year. Arvida Group's return on equity is 5.7%, and it has net margins of 34.2%.
Key information
19.1%
Earnings growth rate
8.5%
EPS growth rate
| Healthcare Industry Growth | 13.0% |
| Revenue growth rate | 10.1% |
| Return on equity | 5.7% |
| Net Margin | 34.2% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Is Arvida Group (NZSE:ARV) Using Too Much Debt?
Jan 03
Arvida Group (NZSE:ARV) Will Pay A Dividend Of NZ$0.0235
Jun 01Does Arvida Group (NZSE:ARV) Have A Healthy Balance Sheet?
Mar 23Results: Arvida Group Limited Beat Earnings Expectations And Analysts Now Have New Forecasts
May 31An Intrinsic Calculation For Arvida Group Limited (NZSE:ARV) Suggests It's 21% Undervalued
May 09With EPS Growth And More, Arvida Group (NZSE:ARV) Is Interesting
Mar 22Does Arvida Group (NZSE:ARV) Deserve A Spot On Your Watchlist?
Oct 21Analysts Just Published A Bright New Outlook For Arvida Group Limited's (NZSE:ARV)
May 27Is Arvida Group Limited (NZSE:ARV) A Good Fit For Your Dividend Portfolio?
Apr 28Read This Before Buying Arvida Group Limited (NZSE:ARV) Shares
Mar 12Arvida Group Limited (NZSE:ARV) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Feb 25Arvida Group Limited's (NZSE:ARV) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 13Arvida Group (NZSE:ARV) Has A Somewhat Strained Balance Sheet
Jan 31What Kind Of Investors Own Most Of Arvida Group Limited (NZSE:ARV)?
Jan 18Here's Why We Don't Think Arvida Group's (NZSE:ARV) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 05Shareholders Of Arvida Group (NZSE:ARV) Must Be Happy With Their 140% Total Return
Dec 23How Many Arvida Group Limited (NZSE:ARV) Shares Have Insiders Sold, In The Last Year?
Dec 10Arvida Group Limited (NZSE:ARV) Passed Our Checks, And It's About To Pay A NZ$0.012 Dividend
Nov 27
Revenue & Expenses BreakdownBeta
How Arvida Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 243 | 83 | 0 | 0 |
| 30 Jun 23 | 233 | 83 | 0 | 0 |
| 31 Mar 23 | 222 | 82 | 0 | 0 |
| 31 Dec 22 | 219 | 148 | 0 | 0 |
| 30 Sep 22 | 217 | 213 | 0 | 0 |
| 30 Jun 22 | 209 | 206 | 0 | 0 |
| 31 Mar 22 | 202 | 199 | 0 | 0 |
| 31 Dec 21 | 192 | 182 | 0 | 0 |
| 30 Sep 21 | 182 | 165 | 0 | 0 |
| 30 Jun 21 | 178 | 148 | 0 | 0 |
| 31 Mar 21 | 174 | 131 | 0 | 0 |
| 31 Dec 20 | 172 | 85 | 0 | 0 |
| 30 Sep 20 | 170 | 39 | 0 | 0 |
| 30 Jun 20 | 167 | 41 | 0 | 0 |
| 31 Mar 20 | 164 | 43 | 0 | 0 |
| 31 Dec 19 | 160 | 58 | 0 | 0 |
| 30 Sep 19 | 156 | 74 | 0 | 0 |
| 30 Jun 19 | 154 | 66 | 0 | 0 |
| 31 Mar 19 | 152 | 59 | 0 | 0 |
| 31 Dec 18 | 150 | 66 | 0 | 0 |
| 30 Sep 18 | 148 | 74 | 1 | 0 |
| 30 Jun 18 | 140 | 66 | 1 | 0 |
| 31 Mar 18 | 132 | 58 | 1 | 0 |
| 31 Dec 17 | 123 | 53 | 1 | 0 |
| 30 Sep 17 | 115 | 49 | 1 | 0 |
| 30 Jun 17 | 108 | 51 | 1 | 0 |
| 31 Mar 17 | 101 | 54 | 1 | 0 |
| 31 Dec 16 | 96 | 45 | 0 | 0 |
| 30 Sep 16 | 90 | 36 | 0 | 0 |
| 30 Jun 16 | 86 | 30 | 0 | 0 |
| 31 Mar 16 | 83 | 24 | 0 | 0 |
| 31 Dec 15 | 71 | 17 | 0 | 0 |
| 30 Sep 15 | 59 | 11 | 0 | 0 |
| 30 Jun 15 | 39 | 7 | 0 | 0 |
| 31 Mar 15 | 20 | 3 | 0 | 0 |
Quality Earnings: ARV has a large one-off gain of NZ$91.9M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: ARV's current net profit margins (34.2%) are lower than last year (98.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARV's earnings have grown by 19.1% per year over the past 5 years.
Accelerating Growth: ARV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ARV had negative earnings growth (-60.8%) over the past year, making it difficult to compare to the Healthcare industry average (-20.1%).
Return on Equity
High ROE: ARV's Return on Equity (5.7%) is considered low.